Growth Metrics

Innoviva (INVA) Net Margin Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 49,253.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 506.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -569.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7,218.00
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn -418,964.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -418,964.00
Dec 31, 2025 -29,133.00
Sep 30, 2025 -2.03 Mn
Jun 30, 2025 1,364.00
Mar 31, 2025 -132,870.00
Dec 31, 2024 -24,183.00
Sep 30, 2024 -7,267.00
Jun 30, 2024 -765,013.00
Mar 31, 2024 -504,860.00
Dec 31, 2023 -1.11 Mn
Sep 30, 2023 9,017.00
Jun 30, 2023 3,327.00
Mar 31, 2023 429,685.00
Dec 31, 2022 -104,317.00
Sep 30, 2022 2.04 Mn
Jun 30, 2022 -900.00
Mar 31, 2022 121,490.00
Dec 31, 2021 -94,181.00
Sep 30, 2021 -232.00
Jun 30, 2021 753,398.00
Mar 31, 2021 877,308.00
Dec 31, 2020 1.06 Mn
Sep 30, 2020 -1,705.00
Jun 30, 2020 3,732.00
Mar 31, 2020 4,157.00
Dec 31, 2019 113.00
Sep 30, 2019 1,541.00
Jun 30, 2019 1,392.00
Mar 31, 2019 4,289.00
Dec 31, 2018 31,145.00
Sep 30, 2018 11,014.00
Jun 30, 2018 15,473.00
Mar 31, 2018 21,116.00
Dec 31, 2017 30,275.00
Sep 30, 2017 217,809.00
Jun 30, 2017 686,558.00
Mar 31, 2017 872,147.00
Dec 31, 2016 344,896.00
Sep 30, 2016 1.14 Mn
Jun 30, 2016 280,055.00
Mar 31, 2016 284,437.00
Dec 31, 2015 -636.00
Sep 30, 2015 239,221.00
Jun 30, 2015 702,422.00
Mar 31, 2015 -22,193.00
Dec 31, 2014 47,141.00
Sep 30, 2014 -165,300.00
Jun 30, 2014 -641,357.00
Mar 31, 2014 -832,184.00